INTERCEPT PHARMACEUTICALS, INC.·4

Feb 16, 4:01 PM ET

Richardson Linda M 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Feb 16, 2023

Insider Transaction Report

Form 4
Period: 2023-02-14
Richardson Linda M
EVP & Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-02-14$21.21/sh386$8,18743,291 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm237050-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT